In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype

Michael Brunner, Sodikdjon A. Kodirov, Gary F. Mitchell, Peter D. Buckett, Katsushi Shibata, Eduardo J. Folco, Linda Baker, Guy Salama, Danny P. Chan, Jun Zhou, Gideon Koren

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Mutations in cardiac voltage-gated K+-channels cause long QT syndrome (LQTS) and sudden death. We created a transgenic mouse with a long QT phenotype (Kv1DN) by overexpression of a truncated K+ channel in the heart and investigated whether the dominant negative effect of the transgene would be overcome by the direct injection of adenoviral vectors expressing wild-type Kv1.5 (AV-Kv1.5) into the myocardium. End points at 3-10 days included electrophysiology in isolated cardiomyocytes, surface ECG, programmed stimulation of the right ventricle, and in vivo optical mapping of action potentials and repolarization gradients in Langendorff-perfused hearts. Overexpression of Kv1.5 reconstituted a 4-aminopyridine-sensitive outward K+ current, shortened the action potential duration, eliminated early afterdepolarizations, shortened the QT interval, decreased dispersion of repolarization, and increased the heart rate. Each of these changes is consistent with a physiologically significant primary effect of adenoviral expression of Kv1.5 on ventricular repolarization of Kv1DN mice.

Original languageEnglish
Pages (from-to)H194-H203
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume285
Issue number1 54-1
DOIs
StatePublished - 1 Jul 2003
Externally publishedYes

Keywords

  • Action potentials
  • Adenovirus
  • Early afterdepolarizations

Fingerprint

Dive into the research topics of 'In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype'. Together they form a unique fingerprint.

Cite this